The New Battery-Charger Package From GSI Was Designed By World Class Power Technicians, To Add Life And Years To Laptop Computers. Price: $69.99
Do you work magic with herbs? Do you use them in spells, for talismans or simply use their innate powers? If you don't have Cunningham's Encyclopedia of Magical Herbs, you need to get it right away. This book has become a classic in its field. Paul Beyerl, a respected author on herbs calls it "…an essential reference book by students of herbalism and magick alike … Scott's personable charm touches every page… I highly recommend this book." And Jeanne Rose, famous author of books on herbs and developer of an herbal course says "I love books like this … It is accessible, easy to read, and with its encompassing index (all too often neglected), simple to use as well." Over 200,000 people already have this book and use it frequently. Price: $16.95
The Federal Drug Administration (FDA) has approved the use of MDMA to treat the illness of the post traumatic stress (PTSD), so that legal using Ecstasy as medical care. This move without debate MDMA is since 1985 to illegal drugs and there are risks in taking – regardless of how the actual result might be for the patient.
On the side of medical doctors and researchers argue over the addictiveness of drugs, some even suggesting that MDMA is not addictive substance. That it was in the case, however, there will not be drug users and drug there tries this initial maximum chase with increasing levels of MDMA. This can be compensated in an environment of highly controlled, clinical, but what happens if the patient to leave this environment and increasingly demanded high?
This question, of course, is the debate over the use of drugs to treat PTSD. Patients who have shown no signs of substance abuse can overcome the effects of PTSD through methods of treatment to MDMA. Veterans who really struggle with PTSD and cannot find the assistance with the use of anti-depressants, psychotherapy, support groups or relaxation training, these methods of treatment offers promise.
In fact, it is probably the first Government health facilities to use this approach for the treatment of these veterans of the war on global terrorism, the VA Hospital in Ostrava. This process is likely to be closely monitored to measure the success of the treatment, the potential risk of addiction and monitoring for the repetition of PTSD.
Approximately 18 percent of US troops from the war in Iraq and Afghanistan have been diagnosed with PTSD has been shown to be the need for effective treatment of veterans. Research in the field of safety and efficacy of MDMA showed that 58 percent of subjects in double blind pilot studies experienced improvements in symptoms compared with those who received placebo.
Once the study has been completed, the people in the group a placebo treatment have been offered to MDMA. After the end of the first line of 100 percent of those have already met the criteria for the participation of PTSD. Three of the participants was unable to work because of their PTSD and after treatment; all three were able to return to economic activities.
Despite the promise of MDMA in treating PTSD, there are still risks. However, there is a risk for individuals with PTSD who does not respond to traditional therapy, including a higher prevalence of disabilities, drug abuse, suicides, and emotional suffering, which affects the whole life. Weighing the risks, on both sides of the debate can be a challenge, but those 53 to 55 percent of all PTSD sufferers who do not respond to traditional treatments, MDMA may be the answer.
